Sponsor pipeline

Hana Serajeddini clinical trial pipeline

Get alerts when Hana Serajeddini's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    SARRE-COMS · Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)

    Primary endpoint(s) modified

    Also in this update: Primary completion moved earlier from Dec 31, 2028 to Oct 31, 2028; Study completion moved earlier from Mar 30, 2029 to Dec 30, 2028

    Hana SerajeddiniNot applicable NCT07816718 Registry history of NCT07816718 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Hana Serajeddini's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free